KELLIE SCHWARTZ: Open Payments
NPI 1184681090 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,626 in 105 payments from 22 companies in 2025. Trend: 2023 $2,363 · 2024 $2,088 · 2025 $2,626
Food & beverage: $2,626
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $481 |
| UCB, Inc. | 13 | $403 |
| Amgen Inc. | 15 | $379 |
| AstraZeneca Pharmaceuticals LP | 7 | $283 |
| GlaxoSmithKline, LLC. | 7 | $195 |
| PFIZER INC. | 14 | $180 |
| Radius Health, Inc. | 1 | $106 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $72 |
| Janssen Biotech, Inc. | 4 | $72 |
| Lilly USA, LLC | 4 | $68 |
Products named: Bimzelx, SKYRIZI, SAPHNELO, EVENITY, BENLYSTA, XELJANZ, RINVOQ, Tymlos.
Industry payments across NY — which companies pay providers there.
